haloperidol has been researched along with senktide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elliott, PJ; Hagan, RM; Mason, GS; Stephens-Smith, M | 1 |
Dourish, CT; Iversen, SD; Stoessl, AJ | 1 |
Alberch, J; Arenas, E; Marsal, J; Pérez-Navarro, E | 1 |
Cenarruzabeitia, E; Del Rio, J; Lasheras, B; Ramírez, MJ | 1 |
Cluderay, JE; Dada, A; Davies, CH; Dawson, LA; de la Flor, R; Hagan, JJ; Hill, MD; Jones, DN; Jones, GA; Langmead, CJ; Murkitt, GS; Smith, PW; Southam, E; Watson, JM; Wu, Z | 1 |
Couture, R; De Brito Gariepy, H | 1 |
6 other study(ies) available for haloperidol and senktide
Article | Year |
---|---|
Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
Topics: Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Dopamine; Haloperidol; Limbic System; Male; Mesencephalon; Molecular Sequence Data; Motor Activity; Neural Pathways; Neurokinin A; Peptide Fragments; Rats; Receptors, Neurotransmitter; Receptors, Tachykinin; Substance P; Substantia Nigra; Tegmentum Mesencephali | 1991 |
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Haloperidol; Hydroxydopamines; Injections, Subcutaneous; Male; Oxidopamine; Parasympathetic Nervous System; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Scopolamine; Stereotyped Behavior; Substance P; Yawning | 1988 |
Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.
Topics: Acetylcholine; Animals; Benzazepines; Clozapine; Dopamine; Dopamine Agents; Haloperidol; In Vitro Techniques; Male; Neostriatum; Neurons; Oxidopamine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Substance P; Tachykinins | 1993 |
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; In Vitro Techniques; Ketanserin; Male; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Physalaemin; Potassium; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Substance P | 1997 |
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics.
Topics: Aminoquinolines; Animals; Behavior, Animal; Brain; Cerebral Cortex; Cloning, Molecular; Dopamine; Extracellular Space; Guinea Pigs; Habenula; Haloperidol; Humans; Inositol Phosphates; Male; Microdialysis; Neurokinin B; Neurons; Nucleus Accumbens; Peptide Fragments; Peptides; Quinolines; Rats; Receptors, Tachykinin; Substance P | 2010 |
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Dopamine; Haloperidol; Heart Rate; Hypertension; Ibotenic Acid; Indoles; Male; Oligopeptides; Peptide Fragments; Quinolines; Raclopride; Rats; Rats, Inbred SHR; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area | 2010 |